Home / Biomedical Advanced Research and Development Authority… / Document

Amendment 6: Changes Table

Updated

A PDF document (155 KB) attached to Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA), from the Office of Assistant Secretary for Preparedness and Response. Due Sep 25, 2028, 4:30 PM (UTC-4).

File name: Amendment_6_Changes_Table.pdf

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview

Change History Table: Original – Amendments (6)
Amendment 6 (May 29, 2025): BARDA BAA-23-100-SOL-00004 List of Changes: Amendment 6 (May 29, 2025)

1. Updates to Introduction

• Updated language under Introduction
• Added additional Disclaimer

2. Updates to Overview Information

• Updated language under Eligible Offerors

3. Updates to Background

• Updated language under Background
• Updated Table 2
4. Updates to Part I: Development and Technical Objectives • Updated language to Development and Manufacturing Approach 5. Updates to Part VI: Proposal Instructions (Stage 3) – Volume II – Cost Proposal Attachments • Rescinded Vol. II, Attachment 13: Procurements Involving Synthetic Nucleic Acid and Screening 6. Updates to Part VII: Proposal Evaluation
• Updated language under Program Relevance
• Added additional Other Evaluation Factors and Considerations for: i. Gain of Function Research
ii. Domestic Based Manufacturing
7. Updates to Part VII: Research and Development Areas of Interest • Added definitions
8. Updates to Area of Interest #1: CBRN Vaccines
• Updated language under introductory paragraph to AOI
• Updated AOI 1.2. Sudan Virus and Marburg Virus
• Updated AOI 1.3. Flexible Vaccine Manufacturing Platform Technologies • Updated AOI 2.2. Botulism Antitoxins
• Updated AOI 2.4. Filovirus Antivirals
9. Updates to Area of Interest #3: Antimicrobials
• Updated language under introductory paragraph to AOI

Amendment 6 (May 29, 2025)
• Updated AOI 3.1. MDR Bacteria and Biothreat Pathogens • Updated AOI 3.2. MDR Fungal Infections
• Updated language under Qualities That Strengthen the Competitiveness of a Proposal 10. Updates to Area of Interest #4: Radiological/Nuclear Threat Medical Countermeasures • Updated language under introductory paragraphs to AOI • Updated AOI 4.1. Acute Radiation Syndrome (ARS)
• Updated AOI 4.2. Uncontrolled Hemorrhage
• Updated AOI 4.3. Radiation Injury and Trauma Pathophysiologies • Updated AOI 4.4. Enabling Technologies and Platforms
• Suspend AOI 4.5. Decorporation Agents
• Updated language under Qualities That Strengthen the Competitiveness of a Proposal 11. Updates to Area of Interest #5: Chemical Medical Countermeasures • Updated language under Qualities That Strengthen the Competitiveness of a Proposal 12. Updates to Area of Interest #6: Burn and Blast Medical Countermeasures • Updated language under introductory paragraphs to AOI • Updated AOI 6.1. Burn and Blast Traumatic Injuries Management, including:

The beginning of the document. Download the full file to read on.

Other documents in this bid